4//SEC Filing
Davis Blaine 4
Accession 0001209191-21-004653
CIK 0001359931other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 3:05 PM ET
Size
5.7 KB
Accession
0001209191-21-004653
Insider Transaction Report
Form 4
Davis Blaine
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-01-19+75,000→ 75,000 totalExercise: $19.82Exp: 2031-01-18→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]25% of the shares vest on the one year anniversary of January 19, 2021 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.
Documents
Issuer
Protara Therapeutics, Inc.
CIK 0001359931
Entity typeother
Related Parties
1- filerCIK 0001802188
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 3:05 PM ET
- Size
- 5.7 KB